Quiet Precision
Immunotherapy
Engineering next-generation T cell engager therapies
with powerful efficacy and meaningfully improved safety.
ABOUT US
Qymune develops next-generation
T cell engager (TCE) platforms designed
to deliver powerful efficacy with meaningfully
improved safety for patients.
OUR PLATFORM
Qymune’s T cell engager platform is engineered to balance efficacy, safety, and durability—without compromise.
Precision Targeting
Precisely engineered engagement ensures selective targeting of pathogenic cells, minimizing off-target interactions and unintended immune responses.
Controlled Activation
Precisely engineered engagement ensures selective targeting of pathogenic cells, minimizing off-target interactions and unintended immune responses.
Safety-by-Design
Safety is embedded at the molecular and platform level, enabling predictable immune behavior rather than relying on downstream management.
Durable Therapeutic Effect
Designed for sustained efficacy through controlled immune engagement, supporting long-term therapeutic benefit without escalating toxicity
OUR VISION
At Qymune, we believe truly safe and effective T-cell engager therapies will redefine what is possible in human healthcare.
Our vision extends beyond oncology to autoimmune and other immune-driven diseases—where precisely removing pathogenic cells can fundamentally change patients’ lives.
By combining deep immunology, antibody engineering, and cutting-edge science, we are reimagining the future of T cell engager therapies—with safety, precision, and durability at the core.
OUR TEAM
Qymune’s T cell engager platform is engineered to balance efficacy, safety, and durability
—without compromise.
CONTACT
953 Indiana St, San Francisco, CA 94107
info@qymune.com
QUICKLINKS
Science
Pipeline
About
Hiring
Newsroom
